News and Events

Sanjeethan "Sanjee" Baksh, eighth year student in the Tri-Institutional MD-PhD Program, has been named 2021 STAT Wunderkind. Dr. Baksh earned his PhD from the Fuchs Lab at The Rockefeller Univeristy in 2020 and will graduate with his MD from Weill Cornell Medicine in 2022.Read more about Sanjee and his award.
Dalton Banh, sixth year student in the Tri-Institutional MD-PhD Program, has been awarded an F30 grant by the National Institutes of Health (NIH).
Fifth year Tri-Institutional MD-PhD student Camila Villasante has been awarded an F30 grant from the National Institutes of Health (NIH).
Yilun Ma, fifth year student in the Tri-Institutional MD-PhD Program, has been awarded an F30 grant from the National Institutes of Health. The award will support Mr. Ma's research in the White Lab at Memorial Sloan Kettering Cancer Center, where he is currently working toward his PhD.
The Olaf S. Andersen Physician-Scientist Award was created to honor the legacy of Dr. Olaf S. Andersen, Program Director of the Tri-Institutional MD-PhD Program from 1996 - 2021. The award will be given annually, starting this year, to an MD-PhD student finishing their 3rd year of medical school.There are seven criteria for the award:
Commentary:
To encourage students from diverse backgrounds to join their ranks, physician-scientist communities must address the significant social, cultural and financial barriers many first-generation college students face in pursuing M.D.-Ph.D. careers, according to a new commentary authored by faculty, a student and staff in the Weill Cornell/Rockefeller/Sloan Kettering Tri-Institutional M.D.–Ph.D. Program. 
On April 8th Weill Cornell Graduate School held the 40th Annual du Vigneaud Research Symposium, this year via remote webcast.The one day symposium featured two poster sessions and two sessions of oral presentations by current WCGS students, along with a keynote address by Dr. Kevan Shokat, of UCSF.
Tri-Institutional MD-PhD student, Abderhman "Abood" Abuhashem, has been awarded an F30 research grant from the National Institutes of Health (NIH). The award will support Mr.
Dr. Katharine (Kathy) Hsu, MD, PhD (Tri-I graduating class of 1994) has been named as the new director of the Tri-Institutional MD-PhD Program. Dr. Hsu, currently a professor at Weill Cornell Graduate School of Medical Sciences and attending hemotologist and oncologist at Memorial Sloan Kettering Cancer Center, where she leads her lab in the study of the ability of natural killer (NK) cells to fight cancer.
Dr.
NEW YORK (April 9, 2021) — Dr. Katharine Hsu, an esteemed physician-scientist who specializes in immunology research and treatment of blood cancers, has been named director of the Tri-Institutional M.D.-Ph.D. Program, a joint program between Weill Cornell Medicine, The Rockefeller University and Memorial Sloan Kettering Cancer Center.